• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.07% Nasdaq Down 0.93%

    Depomed, Inc. (DEPO)

    -NasdaqGS
    23.89 Down 0.64(2.61%) Sep 29, 4:00PM EDT
    Prev Close:24.53
    Open:24.30
    Bid:23.41 x 400
    Ask:25.50 x 400
    1y Target Est:24.08
    Beta:1.46285
    Earnings Date:Nov 7 - Nov 11 (Est.)
    Day's Range:23.52 - 24.53
    52wk Range:12.25 - 25.50
    Volume:2,204,412
    Avg Vol (3m):1,312,610
    Market Cap:1.47B
    P/E (ttm):N/A
    EPS (ttm):-1.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPODown 2.61%1.47B
    PFEDown 1.97%202.11B
    MRKDown 2.20%171.19B

    Key Statistics

    Forward P/E (1 yr):16.14
    P/S (ttm):3.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :1.21
    Quarterly EPS Est (Sep-16) :0.37
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):1.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback